CDE Detailed Report
Disease: Unruptured Cerebral Aneurysms and Subarachnoid Hemorrhage
Subdomain Name: [php]
CRF: ICU Therapies
Displaying 1 - 26 of 26
Subdomain Name: [php]
CRF: ICU Therapies
Displaying 1 - 26 of 26
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C54932 | Hemodynamic therapy specify text | HemodynamicTherapySpecifyTxt | The free-text field related to 'Hemodynamic therapy indicator' for specifying the hemodynamic therapy being given | The free-text field related to 'Hemodynamic therapy indicator' for specifying the hemodynamic therapy being given | Hemodynamic therapy: Yes, specify | Alphanumeric |
Hemodynamic therapy – general: Any goal-directed intervention aimed to influence cardiac output or volume status or blood pressure or any combination |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:44:36.0 | ICU Therapies | [php] | [php_1] | 500 |
Free-Form Entry |
|||||||||
| C54943 | Sodium level unit of measure | SodiumLvlUOM | Unit of measure for recording sodium level | Unit of measure for recording sodium level | Sodium management: Upper/Lower Limit | Alphanumeric |
Units will depend on country of origin. |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:09:39.0 | ICU Therapies | [php] | [php_1] | 50 |
Free-Form Entry |
|||||||||
| C54933 | Hemodynamic augmentation indicator | HemodynamicAugmentatnInd | Indicator of whether hemodynamic augmentation is being given to the subject/participant | Indicator of whether hemodynamic augmentation is being given to the subject/participant | Hemodynamic augmentation | Yes, specify;No | Yes, specify;No | Alphanumeric |
Hemodynamic augmentation – general: An intervention in systemic circulatory status that is aimed at establishing supraphysiological goals in terms of cardiac output or volume status or blood pressure or any combination |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:41:34.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54944 | Ventilation mechanical any indicator | VentlatnMechanclAnyInd | Indicator of whether any mechanical ventilation was administered to the subject/particpant | Indicator of whether any mechanical ventilation was administered to the subject/particpant | Mechanical ventilation (invasive or noninvasive) | No;Yes | No;Yes | Alphanumeric |
Mechanical ventilation: Invasive or noninvasive ventilation at any time excluding strictly procedural/elective mechanical ventilation |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:25:00.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54934 | Hemodynamic augmentation specify text | HemodynamicAugmntatnSpecifyTxt | The free-text field related to 'Hemodynamic augmentation indicator' for specifying the hemodynamic augmentation being given | The free-text field related to 'Hemodynamic augmentation indicator' for specifying the hemodynamic augmentation being given | Hemodynamic augmentation: Yes, specify | Alphanumeric |
Hemodynamic augmentation – general: An intervention in systemic circulatory status that is aimed at establishing supraphysiological goals in terms of cardiac output or volume status or blood pressure or any combination |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:44:36.0 | ICU Therapies | [php] | [php_1] | 500 |
Free-Form Entry |
|||||||||
| C54945 | Ventilation mechanical invasive indicator | VentlatnMechanclInvsvInd | Indicator of whether any invasive mechanical ventilation was administered to the subject/particpant | Indicator of whether any invasive mechanical ventilation was administered to the subject/particpant | Invasive mechanical ventilation | No;Yes | No;Yes | Alphanumeric |
Invasive mechanical ventilation: Yes if intubation and invasive ventilation at any point (regardless if the patient also received non-invasive ventilation before or after) excluding strictly procedural/elective mechanical ventilation |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:25:00.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54935 | Hypervolemic therapy volume augmentation indicator | HyprvlmcThrpyVolmAugmntatnInd | Indicator of whether hypervolemic therapy or volume augmentation is being given to the subject/participant | Indicator of whether hypervolemic therapy or volume augmentation is being given to the subject/participant | Hypervolemic therapy/volume augmentation | Yes, specify;No | Yes, specify;No | Alphanumeric |
Hypervolemic therapy/volume augmentation – general: An intervention aimed at establishing supraphysiological goals in terms of volume status indicated by means of fluid balance and/or- intake, or cardiac output or central venous pressure/pulmonary artery occlusion pressure (CVP/PAOP) or any combination, thus excluding euvolemia |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:41:34.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54946 | Ventilation mechanical noninvasive indicator | VentlatnMechanclNoninvsvInd | Indicator of whether noninvasive mechanical ventilation was administered to the subject/particpant | Indicator of whether noninvasive mechanical ventilation was administered to the subject/particpant | Noninvasive mechanical ventilation | No;Yes | No;Yes | Alphanumeric |
Noninvasive mechanical ventilation: Yes if patient only received non-invasive ventilation (never intubated excluding strictly procedural/elective intubation) during the hospitalization. This variable should be defined as positive pressure NIV and NOT include patients who receive constructive positive airway pressure (CPAP) at night for obstructive sleep apnea (OSA). |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:25:00.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54936 | Hypervolemic therapy volume augmentation specify text | HypvlmcThpyVolmAugmntnSpcfTxt | The free-text field related to 'Hypervolemic therapy volume augmentation' for specifying the hypervolemic therapy or volume augmentation being given | The free-text field related to 'Hypervolemic therapy volume augmentation' for specifying the hypervolemic therapy or volume augmentation being given | Hypervolemic therapy/volume augmentation: Yes, specify | Alphanumeric |
Hypervolemic therapy/volume augmentation – general: An intervention aimed at establishing supraphysiological goals in terms of volume status indicated by means of fluid balance and/or- intake, or cardiac output or central venous pressure/pulmonary artery occlusion pressure (CVP/PAOP) or any combination, thus excluding euvolemia |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:44:36.0 | ICU Therapies | [php] | [php_1] | 500 |
Free-Form Entry |
|||||||||
| C54947 | Ventilation mechanical any total duration | VentlatnMechnclAnyTotlDur | Total duration in days of all mechanical ventilation administered to the subject/particpant | Total duration in days of all mechanical ventilation administered to the subject/particpant | Total length of mechanical ventilation (days, both invasive and noninvasive) | Numeric Values |
Excluding strictly procedural/elective mechanical ventilation and NOT including patients who receive constructive positive airway pressure (CPAP) at night for obstructive sleep apnea (OSA). |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:29:45.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Days | |||||||||
| C54937 | Hypervolemic therapy volume augmentation range | HyprvlmcThrpyVolmAugmntatnRng | Range of hypervolemic therapy/volume augmentation | Range of hypervolemic therapy/volume augmentation | Hypervolemic therapy/volume augmentation - specific goal | Alphanumeric |
Hypervolemic therapy/volume augmentation – specific value: Upper and lower limit of hypervolemic therapy/volume augmentation goal. Fluid balance and/or- intake , or cardiac output or CVP/PAOP or any combination. |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:00:55.0 | ICU Therapies | [php] | [php_1] | 255 |
Free-Form Entry |
|||||||||
| C54948 | Ventilation mechanical invasive total duration | VentlatnMechnclInvsvTotlDur | Total duration in days of invasive mechanical ventilation administered to the subject/particpant | Total duration in days of invasive mechanical ventilation administered to the subject/particpant | Total duration of invasive mechanical ventilation (days) | Numeric Values |
Excluding strictly procedural/elective mechanical ventilation |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:29:45.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Days | |||||||||
| C54927 | Blood pressure systolic target mean measurement | BldPrssrSystlcTrgtMnMeasr | Target measurement for mean systolic blood pressure | Target measurement for mean systolic blood pressure | Routine blood pressure management: upper target mean value (mmHg) | Numeric Values |
Routine upper/lower targets for mean arterial pressure |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:29:39.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Millimeters of mercury | |||||||||
| C54938 | Fever management threshold temperature value | FevrMgmtThreshldTempVal | Value in degrees centigrade of the threshold temperature prompting therapy for fever management | Value in degrees centigrade of the threshold temperature prompting therapy for fever management | Target for fever management target (°C) | Numeric Values |
Fever management target: Elevated body temp that prompts therapy in °C |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211-240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263-277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683-690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129-1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:04:38.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
37 | Degrees centigrade | ||||||||
| C54949 | Ventilation mechanical noninvasive total duration | VentlatnMechnclNonInvsvTotlDur | Total duration in days of noninvasive mechanical ventilation administered to the subject/particpant | Total duration in days of noninvasive mechanical ventilation administered to the subject/particpant | Total duration of noninvasive mechanical ventilation (days) | Numeric Values |
Excluding strictly procedural/elective mechanical ventilation and NOT including patients who receive constructive positive airway pressure (CPAP) at night for obstructive sleep apnea (OSA). |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:29:45.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Days | |||||||||
| C54928 | Blood pressure diastolic target mean measurement | BldPrssrDstlcTrgtMnMeasr | Target measurement for mean diastolic blood pressure | Target measurement for mean diastolic blood pressure | Routine blood pressure management: lower target mean value (mmHg) | Numeric Values |
Routine upper/lower targets for mean arterial pressure |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:29:39.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Millimeters of mercury | |||||||||
| C54939 | Sodium level upper threshold value | SodiumLvlUpThreshldVal | Value of upper sodium threshold level prompting treatment | Value of upper sodium threshold level prompting treatment | Sodium management: Upper Limit | Numeric Values |
Sodium management - upper/lower limit: Upper/lower value of sodium levels that prompt treatment (Units will depend on country of origin). Use 'Sodium unit of measure' to capture units. |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:09:39.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
||||||||||
| C54950 | Intracranial hypertension cerebral edema osmotherapy indicator | IntCrnHyptnsnCrbrlEdmaOsmthInd | Indicator of whether osmotherapy was administered for intracranial hypertension or cerebral edema | Indicator of whether osmotherapy was administered for intracranial hypertension or cerebral edema | Osmotherapy for intracranial hypertension or cerebral edema | Yes, specify;No | Yes, specify;No | Alphanumeric |
Any use of osmotherapy (mannitol, hypertonic saline or others) for treatment of intracranial hypertension or brain edema |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:09:39.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54929 | Mean arterial pressure augmentation measurement | MAPAugmentationMeasr | Measurement of mean arterial pressure (MAP) augmentation | Measurement of mean arterial pressure (MAP) augmentation | Blood pressure augmentation (mmHg): Mean arterial pressure (MAP) | Numeric Values |
Blood pressure augmentation goal: Blood pressure augmentation goal (MAP or systole) beyond routine upper limit of blood pressure for prevention or treatment of delayed cerebral ischemia |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:35:33.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Millimeters of mercury | |||||||||
| C54940 | Blood glucose lower threshold value | BldGlucoseLoThreshldVal | Value of blood glucose lower threshold prompting treatment | Value of blood glucose lower threshold prompting treatment | Glucose control: Lower limit | Numeric Values |
Glucose control – upper/lower limit: Upper/lower value of blood sugar levels that prompt treatment (Units will depend on country of origin). Use 'Blood glucose unit of measure' to capture units. |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:09:39.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
||||||||||
| C54951 | Blood glucose upper threshold value | BldGlucoseUpThreshldVal | Value of blood glucose upper threshold prompting treatment | Value of blood glucose upper threshold prompting treatment | Glucose control: Upper limit | Numeric Values |
Glucose control – upper/lower limit: Upper/lower value of blood sugar levels that prompt treatment (Units will depend on country of origin). Use 'Blood glucose unit of measure' to capture units. |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:09:39.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
||||||||||
| C54930 | Systolic blood pressure augmentation measurement | SystlcBldPrssrAugmentatnMeasr | Measurement of systolic blood pressure augmentation | Measurement of systolic blood pressure augmentation | Blood pressure augmentation (mmHg): Systolic blood pressure (SBP) | Numeric Values |
Blood pressure augmentation goal: Blood pressure augmentation goal (MAP or systole) beyond routine upper limit of blood pressure for prevention or treatment of delayed cerebral ischemia |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:35:33.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
Millimeters of mercury | |||||||||
| C54941 | Blood glucose unit of measure | BloodGlucoseUOM | Unit of measure for reporting blood glucose values | Unit of measure for reporting blood glucose values | Glucose control: Upper/Lower limit: | Alphanumeric |
Units will depend on country of origin |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:15:56.0 | ICU Therapies | [php] | [php_1] | 50 |
Free-Form Entry |
|||||||||
| C54952 | Intracranial hypertension cerebral edema osmotherapy specify text | IntcnlHytnsCblEdmOsmthpySpcTxt | The free-text field related to 'Intracranial hypertension cerebral edema osmotherapy indicator' for specifying the osmotherapy administered | The free-text field related to 'Intracranial hypertension cerebral edema osmotherapy indicator' for specifying the osmotherapy administered | Osmotherapy for intracranial hypertension or cerebral edema: Yes, specify | Alphanumeric |
Osmotherapy: Any use of osmotherapy (mannitol, hypertonic saline or others) for treatment of intracranial hypertension or brain edema |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:47:50.0 | ICU Therapies | [php] | [php_1] | 255 |
Free-Form Entry |
|||||||||
| C54931 | Hemodynamic therapy indicator | HemodynamicTherapyInd | Indicator of whether hemodynamic therapy is being given to the subject/participant | Indicator of whether hemodynamic therapy is being given to the subject/participant | Hemodynamic therapy | Yes, specify;No | Yes, specify;No | Alphanumeric |
Hemodynamic therapy – general: Any goal-directed intervention aimed to influence cardiac output or volume status or blood pressure or any combination |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 12:41:34.0 | ICU Therapies | [php] | [php_1] |
Single Pre-Defined Value Selected |
||||||||
| C54942 | Sodium level lower threshold value | SodiumLvlLoThreshldVal | Value of lower sodium threshold level prompting treatment | Value of lower sodium threshold level prompting treatment | Sodium management: Lower Limit | Numeric Values |
Sodium management - upper/lower limit: Upper/lower value of sodium levels that prompt treatment (Units will depend on country of origin). Use 'Sodium unit of measure' to capture units. |
Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, H?nggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–240. • Suarez JI, Martin RH. Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care. 2010;13(2):263–277. • Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–690. • van der Jagt M. Fluid management of the neurological patient: a concise review. Crit Care. 2016;20(1):126. • van der Jagt M, Haitsma I. An injured brain needs cooling down: no. Intensive Care Med. 2015;41(6):1129–1131 | Adult;Pediatric | Supplemental | 1.00 | 2017-04-13 13:09:39.0 | ICU Therapies | [php] | [php_1] |
Free-Form Entry |
